$10.610
+0.341 (+3.21%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
TTRX-Prognose durch Analyse ähnlicher Charts
Alphio's TTRX stock price prediction model matches the current Turn Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.45 (+0.30%). The 1-week path is $10.76 (+3.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Turn Therapeutics Inc-Aktien kaufen?
Turn Therapeutics Inc. (TTRX) is a good buy right now, as it is currently priced at $10.28, significantly lower than the analyst price target of $24, indicating a potential upside of 134%. Additionally, the recent Phase 2 trial results for GX-03 show that 92.6% of participants achieved a 50% reduction in eczema severity, which could drive future revenue growth. The main risk is the company's high debt to equity ratio of 882.68%, which indicates significant financial leverage and potential vulnerability.
TTRX schloss am Monday bei $10.61, nachdem der Kurs +3.21% gestiegen ist
Turn Therapeutics Inc (TTRX) last closed at $10.4200001, losing -1.79%. These facts feed the 1-day and 1-week TTRX price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Turn Therapeutics Inc (TTRX) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf TTRX am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für TTRX
Historically the probability of a positive October return for TTRX is 50.00%. June offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.